https://thehealthtechsignal.com/newsletters/athenahealth-lets-patients-bring-their-records-into-anthropic-s-claude The HealthTech Signalen 2026-11-03T09:15:38.000Z athenahealth Lets Patients Bring Their Records Into Anthropic's Claude https://thehealthtechsignal.com/signal/2026-11-03 The HealthTech Signalen 2026-11-03T09:00:00.000Z Athenahealth connects patient portal records directly to Anthropic's Claude https://thehealthtechsignal.com/article/athenahealth-claude-patient-directed-ai-record-access The HealthTech Signalen 2026-11-03T09:00:00.000Z The Record Leaves the Building: athenahealth, Claude and the Rise of Patient-Directed AI Access https://thehealthtechsignal.com/article/ceribell-delirium-icu-neuromonitoring-economics The HealthTech Signalen 2026-11-03T09:00:00.000Z A Second Indication on the Same Headband: Ceribell, Delirium and the Economics of ICU Neuromonitoring https://thehealthtechsignal.com/article/biossil-theriva-ai-drug-redevelopment The HealthTech Signalen 2026-11-03T09:00:00.000Z Buying Second Chances: Biossil, Theriva and the AI-Native Bet on Shelved Drugs https://thehealthtechsignal.com/signal/2026-11-02 The HealthTech Signalen 2026-11-02T09:00:00.000Z CT-Guided PCI Planning Matches Ultrasound Outcomes in Heartflow Clinical Trial https://thehealthtechsignal.com/article/p4-trial-ct-ivus-upstream-pci-planning The HealthTech Signalen 2026-11-02T09:00:00.000Z Planning Moves Upstream: What the P4 Trial Means for CT, IVUS and the Economics of the Cath Lab https://thehealthtechsignal.com/article/voceryq-cellectra-device-delivered-dna-medicine The HealthTech Signalen 2026-11-02T09:00:00.000Z Device and Drug as One Product: VOCERYQ, CELLECTRA and the Commercial Test for DNA Medicines https://thehealthtechsignal.com/article/australia-cdss-exemption-clinical-ai-transparency The HealthTech Signalen 2026-11-02T09:00:00.000Z Show Your Working: Australia's CDSS Exemption, the AI Scribe Review and the Transparency Test for Clinical AI https://thehealthtechsignal.com/newsletters/ct-guided-pci-planning-matches-ivus-in-the-1-105-patient-p4-trial-at-tct-2026 The HealthTech Signalen 2026-11-02T08:00:00.000Z CT-Guided PCI Planning Matches IVUS in the 1,105-Patient P4 Trial at TCT 2026